Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vedat Çilingir

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Clinical Respiratory Journal|August 11, 2020
Cognitive dysfunction among patients in chronic obstructive pulmonary disease: Effects of exacerbation and long-term oxygen therapyBuket Mermit Çilingir, Hülya Günbatar, Vedat Çilingir
Clinical Nuclear Medicine|July 13, 2015
Dyke-Davidoff-Masson Syndrome With Cerebral Hypometabolism and Unique Crossed Cerebellar Diaschisis in 18F-FDG PET/CTYusuf Demir, Erdem Sürücü, Vedat Çilingir, et al.
Wiener Klinische Wochenschrift|April 10, 2015
Serum antioxidant enzymes activities and oxidative stress levels in patients with acute ischemic stroke: influence on neurological status and outcomeAysel Milanlioglu, Mehmet Aslan, Halil Ozkol, et al.
Seminars in Ophthalmology|September 16, 2016
Ultrasonic Elastography Evaluation in Optic NeuritisMuhammed Batur, Abdussamet Batur, Vedat Çilingir, et al.
Postepy Dermatologii I Alergologii|July 20, 2019
Effects of omalizumab therapy on peripheral nerve functions: short observational studyGoknur Ozaydın Yavuz, Abdullah Yılgör, Ibrahim Halil Yavuz, et al.
Noro Psikiyatri Arsivi|September 26, 2022
A Rare Central Nervous System Involvement Due to CTLA-4 Gene DefectSahib Rovshanov, Rahşan Göçmen, İbrahim Barişta, et al.
Multiple Sclerosis and Related Disorders|February 9, 2024
The role of oligoclonal band count and IgG index in treatment response and disease activity in multiple sclerosisEsra Taşkıran, Murat Terzi, Elif Merve Helvacı, et al.
Multiple Sclerosis and Related Disorders|June 26, 2025
Safety and Efficacy of Cladribine in Patients Discontinuing Fingolimod Due to Elevated Transaminase Levels: The FinClad StudyMeryem Tuba Sönmez, Mehmet Fatih Yetkin, Duygu Arslan Mehdiyev, et al.
Noro Psikiyatri Arsivi|March 13, 2023
Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod TreatmentMurat Terzi, Elif Merve Helvacı, Sedat Şen, et al.
Balkan Medical Journal|June 3, 2024
Clinical, Demographic, and Radiological Characteristics of Patients Demonstrating Antibodies Against Myelin Oligodendrocyte GlycoproteinSümeyye Koç, Sedat Şen, Yüksel Terzi, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Clinical Respiratory Journal|August 11, 2020
Cognitive dysfunction among patients in chronic obstructive pulmonary disease: Effects of exacerbation and long-term oxygen therapyBuket Mermit Çilingir, Hülya Günbatar, Vedat Çilingir
Clinical Nuclear Medicine|July 13, 2015
Dyke-Davidoff-Masson Syndrome With Cerebral Hypometabolism and Unique Crossed Cerebellar Diaschisis in 18F-FDG PET/CTYusuf Demir, Erdem Sürücü, Vedat Çilingir, et al.
Wiener Klinische Wochenschrift|April 10, 2015
Serum antioxidant enzymes activities and oxidative stress levels in patients with acute ischemic stroke: influence on neurological status and outcomeAysel Milanlioglu, Mehmet Aslan, Halil Ozkol, et al.
Seminars in Ophthalmology|September 16, 2016
Ultrasonic Elastography Evaluation in Optic NeuritisMuhammed Batur, Abdussamet Batur, Vedat Çilingir, et al.
Postepy Dermatologii I Alergologii|July 20, 2019
Effects of omalizumab therapy on peripheral nerve functions: short observational studyGoknur Ozaydın Yavuz, Abdullah Yılgör, Ibrahim Halil Yavuz, et al.
Noro Psikiyatri Arsivi|September 26, 2022
A Rare Central Nervous System Involvement Due to CTLA-4 Gene DefectSahib Rovshanov, Rahşan Göçmen, İbrahim Barişta, et al.
Multiple Sclerosis and Related Disorders|February 9, 2024
The role of oligoclonal band count and IgG index in treatment response and disease activity in multiple sclerosisEsra Taşkıran, Murat Terzi, Elif Merve Helvacı, et al.
Multiple Sclerosis and Related Disorders|June 26, 2025
Safety and Efficacy of Cladribine in Patients Discontinuing Fingolimod Due to Elevated Transaminase Levels: The FinClad StudyMeryem Tuba Sönmez, Mehmet Fatih Yetkin, Duygu Arslan Mehdiyev, et al.
Noro Psikiyatri Arsivi|March 13, 2023
Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod TreatmentMurat Terzi, Elif Merve Helvacı, Sedat Şen, et al.
Balkan Medical Journal|June 3, 2024
Clinical, Demographic, and Radiological Characteristics of Patients Demonstrating Antibodies Against Myelin Oligodendrocyte GlycoproteinSümeyye Koç, Sedat Şen, Yüksel Terzi, et al.
Pageof 2